Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetic–Pharmacodynamic Relationship: Problems01:24

Pharmacokinetic–Pharmacodynamic Relationship: Problems

126
The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
126
Pharmacokinetics: Overview01:10

Pharmacokinetics: Overview

9.6K
Pharmacokinetics is a scientific discipline that focuses on the journey of a drug within the body, encompassing four key stages: absorption, distribution, metabolism, and elimination. The first stage, absorption, involves the drug's transfer into the bloodstream. Several factors dictate the extent and speed of this process. For example, the liver often metabolizes oral drugs before they reach systemic circulation, leading to only partial absorption. In contrast, intravenous (IV)...
9.6K
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

362
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
362
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

544
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
544
Measurement of Bioavailability: Pharmacokinetic Methods01:30

Measurement of Bioavailability: Pharmacokinetic Methods

510
Pharmacokinetics is a vital branch of pharmacology that examines how drugs are absorbed, distributed, metabolized, and excreted by the body. Two key methodologies in pharmacokinetics are plasma drug concentration studies and urinary drug excretion analyses, both of which provide critical insights into a drug's therapeutic efficacy and bioavailability.Plasma Drug Concentration-Time StudiesPlasma drug concentration-time studies involve analyzing blood samples at specific intervals to quantify...
510
Pharmacokinetic–Pharmacodynamic Relationship: Model Components01:14

Pharmacokinetic–Pharmacodynamic Relationship: Model Components

225
Pharmacokinetic-pharmacodynamic (PK–PD) modeling is essential in drug development and clinical pharmacology. It provides a quantitative framework to predict drug behavior and response over time. This approach integrates pharmacokinetics (PK), which describes the drug's absorption, distribution, metabolism, and excretion, with pharmacodynamics (PD), which characterizes the drug’s biological effects and mechanisms of action.The disposition kinetics of a drug determine its plasma...
225

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

What do I need to know about glycopeptide antibiotics?

Archives of disease in childhood. Education and practice edition·2016
Same author

Research with children and young people: not on them.

Archives of disease in childhood·2016
Same author

Drug allergy: diagnosis and management of drug allergy in adults, children and young people; a look at NICE guidance.

Archives of disease in childhood. Education and practice edition·2016
Same author

Intravenous salbutamol for childhood asthma: evidence-based medicine?

Archives of disease in childhood·2014
Same author

General anaesthesia or sedation for paediatric neuroimaging: current practice in a teaching hospital.

Archives of disease in childhood·2010
Same author

Sedation for radiological imaging.

Archives of disease in childhood. Education and practice edition·2010

Related Experiment Video

Updated: Apr 25, 2026

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
10:02

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs

Published on: July 23, 2016

30.6K

Practical pharmacokinetics: what do you really need to know?

E S Starkey1, H M Sammons2

  • 1Derbyshire Children's Hospital, Derby, UK.

Archives of Disease in Childhood. Education and Practice Edition
|August 15, 2014
PubMed
Summary

Understanding pharmacokinetics is crucial for safe medication prescribing in children. This article explains basic pediatric pharmacokinetic principles to help clinicians avoid underdosing or overdosing, ensuring effective and safe pediatric treatments.

Keywords:
General PaediatricsPaediatric PracticePharmacologyTherapeutics

More Related Videos

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
08:59

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment

Published on: December 3, 2020

7.3K
A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

17.4K

Related Experiment Videos

Last Updated: Apr 25, 2026

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
10:02

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs

Published on: July 23, 2016

30.6K
An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
08:59

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment

Published on: December 3, 2020

7.3K
A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

17.4K

Area of Science:

  • Pharmacology
  • Pediatrics
  • Clinical Pharmacy

Background:

  • Effective medication prescribing requires understanding pharmacokinetics to prevent underdosing or toxicity.
  • Pediatric patients present unique physiological and developmental differences complicating safe drug administration.
  • Clinicians need accessible knowledge of pediatric pharmacokinetics for optimal patient outcomes.

Purpose of the Study:

  • To provide clinicians with fundamental pediatric pharmacokinetic principles.
  • To enhance safe and effective medication prescribing in pediatric populations.
  • To offer practical clinical examples illustrating pharmacokinetic concepts in children.

Main Methods:

  • Review of established pharmacokinetic principles.
  • Application of principles to pediatric physiology and development.
  • Inclusion of clinical case examples for practical guidance.

Main Results:

  • Pharmacokinetic processes (absorption, distribution, metabolism, excretion) differ significantly in pediatric patients.
  • Age-related physiological changes impact drug disposition and response.
  • Understanding these differences is key to adjusting pediatric drug dosages.

Conclusions:

  • Basic knowledge of pediatric pharmacokinetics is essential for all clinicians.
  • Applying pharmacokinetic principles improves medication safety and efficacy in children.
  • Clinical examples aid in translating pharmacokinetic theory into practice for pediatric prescribing.